T1	Participants 675 772	Patients > or =1 year of age with a parasite density > or =1,000 asexual parasites per microliter
T2	Participants 802 967	Forty-four percent (24 of 54) of the CQ-treated patients were therapeutic failures, including 7 early treatment failures (ETFs) and 17 late treatment failures (LTFs)
